Kyle Gano

Chief Executive Officer, Director, Neurocrine Biosciences

Bought, 12 months

$0.0M

Sold, 12 months

$4.9M

Companies

Latest trade

Jan 16, 2026

Companies

Neurocrine BiosciencesChief Executive Officer, Director −$4.9M

Trades

NBIX Sold 36,400 shares at $132.70 · planned $4.8M Jan 16

NBIX Sold 300 shares at $141.97 · planned $0.0M Nov 4

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.